UG Healthcare Corp. Ltd.

UG Healthcare Corp. Ltd.

SSGX:8K7
0.07
SGD
+0.00
(-1.33%)
0.00EPS
4.45P/E
9.15MMarket Cap
Feb 10Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.09
0.1
0.1
0.11
0.14
0.16
0.25
0.55
0.38
0.16
0.18
0.23
0.24
0.18
Basic EPS, GAAP
0.01
0.01
0.01
- -
0.01
- -
0.02
0.19
0.06
-0.03
-0.01
-0.01
- -
- -
Free Cash Flow per Basic Share
- -
- -
-0.01
-0.02
-0.01
-0.03
0.01
0.1
0.05
-0.07
-0.02
-0.01
0.02
-0.02
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
- -
- -
- -
- -
Book Value per Share
0.05
0.07
0.07
0.06
0.07
0.07
0.09
0.31
0.37
0.29
0.27
0.25
0.28
0.07
Tangible Book Value per Share
0.05
0.06
0.07
0.06
0.07
0.07
0.09
0.31
0.37
0.29
0.23
0.22
0.24
0.07
Basic Weighted Avg Shares
564
564
564
574
574
580
588
611
620
624
624
624
624
582
Sales/Revenue/Turnover
49
56
59
65
78
92
144
338
233
101
115
144
151
103
Operating Margin (%)
11.51
6.09
7.88
2
2.7
3.96
17.2
46.04
22
-24.84
-5.75
-0.57
3.68
3.1
Depreciation Expense
1
1
1
1
1
2
2
3
4
3
4
4
6
2
Net Income, GAAP
5
3
5
2
4
3
13
119
37
-21
-4
-4
2
2
Effective Tax Rate (%)
19.87
25.9
26.11
15.14
14.54
19.76
16.45
24.75
18.38
- -
- -
- -
33.8
30.76
Profit Margin (%)
10
5.68
9.27
3.75
5.55
2.73
9.29
35.1
15.82
-20.5
-3.44
-2.63
1.39
1.96
Working Capital
17
22
20
15
19
15
25
139
176
127
98
87
88
13
LT Debt
4
4
3
2
5
6
5
6
11
14
25
23
19
5
Total Equity
30
37
38
37
42
43
54
195
235
181
166
156
170
43
Return on Invested Capital (%)
- -
8.92
11.22
2.11
2.91
3.87
24.02
73.56
17.2
- -
- -
- -
2.25
2.79
Return on Capital (%)
- -
9.26
11.96
5.96
8.03
5.45
15.59
78.32
14.83
- -
- -
- -
1.56
4.89
Return on Common Equity (%)
- -
9.46
14.52
6.49
10.96
5.95
28.35
97.81
17.54
-10.12
-2.27
-2.32
1.27
4.82

Capital Structure

SGD

•

in mil. unless spec.
Jun'19
Sep'20
Dec'20
ST Debt
32
34
36
LT Borrowings
6
6
5
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
580
580
588
Market Capitalization
11
11
9

Working Capital

SGD

•

in mil. unless spec.
Jun'19
Sep'20
Dec'20
Total Current Assets
62
64
68
Cash, Cash Equivalents & STI
5
5
4
Accounts Receivable, Net
20
24
24
Inventories
31
35
39
Total Current Liabilities
46
50
54
Payables & Accruals
- -
- -
- -
ST Debt
32
34
36
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
28.94%
-1.57%
8.61%
Free Cash Flow
10.04%
-133.59%
-274.52%
Net Income, GAAP
73.5%
-93.15%
-155.32%
Sales/Revenue/Turnover
19.58%
-8.83%
4.69%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
115
2025
- -
- -
144
2026
- -
- -
151

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.01
2025
- -
- -
-0.01
2026
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Jun Linn Lee
Full Time Employees
743
Sector
Health technology
Industry
Medical specialties
Address
5 Shenton Way Singapore CE Singapore 068808
IPO Date
Dec 8, 2014
Business
UG Healthcare Corporation Limited (SGX:8K7), an investment holding company founded in 1989 and headquartered in Singapore, manufactures and markets proprietary UNI GLOVES branded disposable examination gloves and ancillary healthcare products through an integrated own-brand manufacturing supply chain. The Group operates upstream manufacturing facilities in Seremban, Malaysia, certified to ISO 9001:2015, ISO 13485:2016, EN ISO 13485:2016, and ISO 14971:2019 standards for natural latex and nitrile examination gloves; it produces latex examination gloves, nitrile examination gloves, surgical gloves, vinyl gloves, cleanroom disposable gloves, reusable gloves for heavy industries, face masks, and other medical disposables focused on infection control, hygiene, dental care, and wound care. Downstream, the Group maintains a global distribution network with local presence in Europe, the United Kingdom, the USA, China, Africa, and South America, serving healthcare, industrial, and hygiene sectors across developed and developing markets. The Group has strategically diversified into non-glove healthcare businesses, including joint development and operation of active retirement homes in Malaysia. Recent developments include the full acquisition of remaining shares in Unigloves Germany in May 2024 for EUR16.9 million, granting complete ownership of the European associate; formation of a joint venture via 50% acquisition of UG Nitrex S.L. in Spain in June 2024 for EUR500,000 to expand into reusable gloves, safety footwear, and personal protective equipment for industrial applications, with put-and-call options for full control from July 2027; and an increase in equity interest in Health Focus Diagnostics Nigeria (Pty) Limited in May 2024. In late 2024, board changes featured retirements of executive director Wong See Keong and independent directors Yip Wah Pung and Ng Lip Chi Lawrence, alongside appointments of non-executive chairman Sunny Wong Fook Choy and independent director Law Cheong Yan in November, and reconstitution of board committees. Subsidiaries such as N.S. Uni-Gloves Sdn Bhd, UG Glovetech Sdn Bhd, and Unigloves (Singapore) Pte Ltd support manufacturing, engineering, and marketing operations.